MedTrace Logo

Anderson Study 1 - Tart Cherry Study

NCT04837274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-06-27

No results posted yet for this study

Summary

The purpose of this study is to examine if tart cherry reduces food-induced elevations in serum uric acid.

Conditions

  • Health Services Research

Interventions

DIETARY_SUPPLEMENT

Placebo

Dextrose (480 mg)

DIETARY_SUPPLEMENT

Active

Tary Cherry (480 mg)

Sponsors & Collaborators

Principal Investigators

  • Richard B Kreider, PhD · Texas A&M University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-10
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04837274 on ClinicalTrials.gov